SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 200 filers reported holding SAGE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,505 | -41.8% | 138,618 | +0.5% | 0.00% | -100.0% |
| Q1 2024 | $2,584 | -52.5% | 137,914 | -45.1% | 0.00% | -50.0% |
| Q4 2023 | $5,440 | +28.1% | 251,060 | +21.6% | 0.00% | -33.3% |
| Q3 2023 | $4,248 | -37.2% | 206,413 | +43.4% | 0.00% | -25.0% |
| Q2 2023 | $6,769 | +9.7% | 143,959 | -2.1% | 0.00% | +33.3% |
| Q1 2023 | $6,171 | +68.0% | 147,062 | +52.7% | 0.00% | +50.0% |
| Q4 2022 | $3,673 | -99.9% | 96,323 | -8.8% | 0.00% | -60.0% |
| Q3 2022 | $4,134,000 | +1906.8% | 105,566 | +1547.7% | 0.01% | – |
| Q2 2022 | $206,000 | -83.3% | 6,407 | -82.8% | 0.00% | -100.0% |
| Q1 2022 | $1,235,000 | -77.1% | 37,297 | -70.6% | 0.00% | 0.0% |
| Q4 2021 | $5,390,000 | +140.9% | 126,704 | +151.1% | 0.00% | 0.0% |
| Q3 2021 | $2,237,000 | +39.0% | 50,467 | +78.3% | 0.00% | 0.0% |
| Q2 2021 | $1,609,000 | -66.7% | 28,310 | -56.1% | 0.00% | -66.7% |
| Q1 2021 | $4,829,000 | +1291.6% | 64,532 | +1509.7% | 0.00% | – |
| Q4 2020 | $347,000 | +48.9% | 4,009 | +5.3% | 0.00% | – |
| Q3 2020 | $233,000 | -68.6% | 3,806 | -78.7% | 0.00% | -100.0% |
| Q2 2020 | $741,000 | -73.4% | 17,856 | -81.6% | 0.00% | -50.0% |
| Q1 2020 | $2,787,000 | -72.7% | 97,024 | -31.3% | 0.00% | -60.0% |
| Q4 2019 | $10,193,000 | -7.1% | 141,219 | +80.6% | 0.01% | -28.6% |
| Q3 2019 | $10,972,000 | -32.2% | 78,209 | -11.5% | 0.01% | -30.0% |
| Q2 2019 | $16,173,000 | +450.3% | 88,334 | +378.0% | 0.01% | +400.0% |
| Q1 2019 | $2,939,000 | -86.2% | 18,478 | -91.7% | 0.00% | -87.5% |
| Q4 2018 | $21,312,000 | +467.0% | 222,488 | +735.9% | 0.02% | +700.0% |
| Q3 2018 | $3,759,000 | -65.1% | 26,615 | -61.4% | 0.00% | -77.8% |
| Q2 2018 | $10,782,000 | +303.5% | 68,877 | +315.0% | 0.01% | +800.0% |
| Q1 2018 | $2,672,000 | -97.6% | 16,597 | -97.5% | 0.00% | -98.9% |
| Q4 2017 | $111,020,000 | +1800.1% | 674,030 | +618.6% | 0.09% | +1400.0% |
| Q3 2017 | $5,843,000 | -89.4% | 93,793 | -86.4% | 0.01% | -89.8% |
| Q2 2017 | $54,900,000 | +23064.6% | 689,355 | +20595.1% | 0.06% | – |
| Q1 2017 | $237,000 | -93.2% | 3,331 | -95.1% | 0.00% | -100.0% |
| Q4 2016 | $3,476,000 | -48.9% | 68,104 | -53.9% | 0.00% | -50.0% |
| Q3 2016 | $6,803,000 | -55.8% | 147,722 | -71.1% | 0.01% | -60.0% |
| Q2 2016 | $15,376,000 | +19868.8% | 510,331 | +21217.1% | 0.02% | – |
| Q1 2016 | $77,000 | +133.3% | 2,394 | +319.3% | 0.00% | – |
| Q4 2015 | $33,000 | -93.6% | 571 | -95.4% | 0.00% | -100.0% |
| Q3 2015 | $516,000 | +6.2% | 12,288 | +84.6% | 0.00% | – |
| Q2 2015 | $486,000 | +1925.0% | 6,656 | +1313.2% | 0.00% | – |
| Q1 2015 | $24,000 | +14.3% | 471 | -16.9% | 0.00% | – |
| Q4 2014 | $21,000 | – | 567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 255,000 | $18,123,000 | 10.69% |
| Clarius Group, LLC | 149,068 | $10,594,000 | 4.38% |
| GREAT POINT PARTNERS LLC | 301,809 | $21,450,000 | 4.26% |
| GREAT POINT PARTNERS LLC | 300,000 | $21,321,000 | 4.23% |
| Sio Capital Management, LLC | 102,800 | $7,306,000 | 4.09% |
| Palo Alto Investors LP | 1,101,951 | $78,316,000 | 3.70% |
| New Leaf Venture Partners, L.L.C. | 99,123 | $7,045,000 | 3.61% |
| DLD Asset Management, LP | 245,800 | $17,466,000 | 2.80% |
| First Light Asset Management, LLC | 93,465 | $6,643,000 | 2.54% |
| DLD Asset Management, LP | 220,300 | $15,655,000 | 2.51% |